Abstract
This research service analyses the latest developments that has occurred in the field of cancer vaccines, both from a technology and industry perspective.
Table of Contents
1 EXECUTIVE SUMMARY
- Research Scope and Methodology
- Research Scope
- Research Methodology
- Industry Overview; Trends; and Key Findings
- Industry Overview and Trends
- Noteworthy Developments
2 TECHNOLOGY ADOPTION FACTOR ANALYSIS
- Technology Primer
- Cancer--A Malignant Malady
- The Immune Escape of Cancer
- Cancer Vaccines--An Introduction
- Therapeutic Vaccines in the Spotlight--Waking up the Immune System to Treat Cancer
- Technology and Industry Drivers; Challenges
- Technology and Industry Drivers
- Technology and Industry Barriers and Challenges
- Strategic Evaluation of the Competitive Environment
- A Strategic Evaluation of the Cancer Vaccine Space-SWOT Analysis
- Key Collaborations and Corporate Deals in the Cancer Vaccine Sector--An Impact Analysis
- Pipeline Insight--Cancer Vaccines in the Lead
- Current Trends; Future Outlook; and Strategic Recommendations (Analyst' s
Perspectives)
- Cancer Vaccine Industry Trends-A Turbulent Path toward Success
- Cancer Vaccine Future Outlook-From Pipeline to Approved Products
- Strategic Recommendations--Converting Challenge to Success
3 ON-GOING R & D HIGHLIGHTS IN THE CANCER VACCINE SPACE
- Corporate Profiles--World
- From Cell-Lines to off-the-shelf Immunotherapies-Creating an Impact in Cancer Therapeutics--USA
- Liposomal Vaccines-Leading the Way in NSCLC Therapeutics--USA
- Vaccine to Attack the Pregnancy Hormone-A Novel Theme to Tame Cancer--USA
- Yeast Vector-Based Vaccines-A Novel Paradigm of Cancer Vaccine Development--USA
- RNA-Loaded Dendritic Cells--Paving the Way for a New Generation of Personalized Cancer Vaccines--USA
- Consolidated Immunotherapeutic Technologies as a Dynamic Tool to Combat Cancer--Denmark
- A Cocktail of Approaches to Wake up the Immune System against Cancer--USA
- Viral Vector Vaccines Inspire a Robust Mechanism of Immunization against a Wide Spectrum of Cancer Indications--France
- Multiantigen Viral Vector Vaccines-Generating Broader Immune Responses--USA
- Listeria-Based Vaccines-A Potent Bacterium-Based Stimulation of Immune System--USA
- Telomerase Targeting Vaccines-Inciting Optimism to Deliver Targeted Cancer Therapy--USA
- Academic Profiles--USA
- Encouraging Results Reveal Pioneering Pancreatic Cancer Treatment
- Vaccine Strategy Aims at Molecular Targets for Head and Neck Cancer
- Embryonic Stem Cells Suggest an Exciting Possibility toward Lung Cancer Treatment in Mice
- Researchers Embark on a Novel Approach to Prevent Breast Cancer
4 INTELLECTUAL PROPERTY (IP) SCENARIO; KEY CONTACTS
- The IP Scenario
- Key Industry Patents
- Key Academic Patents
- Key Contacts
- Key Industry Contacts
- Key Academic Contacts
5 DECISION SUPPORT DATABASE TABLES
- Database Tables
- Pharmaceutical R&D Expenditure--World (2002 to 2012)
- Mortality of Prostrate Cancer--World (2002 to 2012)
- Mortality of Lung Cancer--World (2002 to 2012)
- Incidence of Breast Cancer--World (2002 to 2012)
- Incidence of Colon Rectum Cancer--World (2002 to 2012)
